KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)

$7.82 -0.08 (-1.0127%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 75

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) News Sources

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

20-04-2026

yahoo.com

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

21-04-2026

yahoo.com

Kyverna Therapeutics Showcases miv-cel Data in SPS, gMG; CEO Eyes First Autoimmune CAR-T BLA

25-04-2026

marketbeat.com

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

04-05-2026

yahoo.com

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

12-05-2026

yahoo.com

Assertio accepts new buyout bid; AI biotech Isomorphic banks $2B

13-05-2026

biopharmadive.com

Kyverna Therapeutics to Present at Upcoming Investor Conferences

14-05-2026

yahoo.com

KYV-101 Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

15-05-2026

yahoo.com

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

18-05-2026

yahoo.com

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

03-06-2026

yahoo.com

KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) Sentiment Trend

0 25 50 75 100 78 75 84 80 51 81 82 79 70 66 20-04-2026 21-04-2026 25-04-2026 04-05-2026 12-05-2026 13-05-2026 14-05-2026 15-05-2026 18-05-2026 03-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) FAQs

toggle

What is the current price of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?

The current price of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is $7.82.


toggle

KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) since the previous trading day is $-0.08.


toggle

KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) since the previous trading day is -1.0127%.


toggle

What is the most recent average sentiment score for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?

The most recent average sentiment score for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is 75 out of 100.


toggle

What is the most recent average sentiment for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)?

The most recent sentiment for KYVERNA THERAPEUTICS INC (KYTX:NASDAQ) is .


SEC-8K** Filing Available For KYVERNA THERAPEUTICS INC (KYTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.